1. Home
  2. MDAIW vs GLUE Comparison

MDAIW vs GLUE Comparison

Compare MDAIW & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAIW
  • GLUE
  • Stock Information
  • Founded
  • MDAIW N/A
  • GLUE 2019
  • Country
  • MDAIW United States
  • GLUE United States
  • Employees
  • MDAIW 78
  • GLUE N/A
  • Industry
  • MDAIW Medical/Dental Instruments
  • GLUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • MDAIW Health Care
  • GLUE Health Care
  • Exchange
  • MDAIW Nasdaq
  • GLUE Nasdaq
  • Market Cap
  • MDAIW N/A
  • GLUE N/A
  • IPO Year
  • MDAIW N/A
  • GLUE 2021
  • Fundamental
  • Price
  • MDAIW $0.31
  • GLUE $4.09
  • Analyst Decision
  • MDAIW
  • GLUE Buy
  • Analyst Count
  • MDAIW 0
  • GLUE 3
  • Target Price
  • MDAIW N/A
  • GLUE $14.33
  • AVG Volume (30 Days)
  • MDAIW 35.6K
  • GLUE 538.3K
  • Earning Date
  • MDAIW 02-27-2025
  • GLUE 05-08-2025
  • Dividend Yield
  • MDAIW N/A
  • GLUE N/A
  • EPS Growth
  • MDAIW N/A
  • GLUE N/A
  • EPS
  • MDAIW N/A
  • GLUE 0.08
  • Revenue
  • MDAIW $27,264,000.00
  • GLUE $159,487,000.00
  • Revenue This Year
  • MDAIW N/A
  • GLUE N/A
  • Revenue Next Year
  • MDAIW N/A
  • GLUE N/A
  • P/E Ratio
  • MDAIW N/A
  • GLUE $52.78
  • Revenue Growth
  • MDAIW 44.52
  • GLUE 14889.38
  • 52 Week Low
  • MDAIW $0.08
  • GLUE $3.21
  • 52 Week High
  • MDAIW $0.90
  • GLUE $12.40
  • Technical
  • Relative Strength Index (RSI)
  • MDAIW N/A
  • GLUE 39.06
  • Support Level
  • MDAIW N/A
  • GLUE $3.76
  • Resistance Level
  • MDAIW N/A
  • GLUE $4.62
  • Average True Range (ATR)
  • MDAIW 0.00
  • GLUE 0.37
  • MACD
  • MDAIW 0.00
  • GLUE -0.05
  • Stochastic Oscillator
  • MDAIW 0.00
  • GLUE 19.30

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: